Infectious diseases

Prof Adrian Esterman
Podcasts iconPodcasts

Molnupiravir is still effective and protecting your most vulnerable patients

Prof Frances Williams
Clinical Articles iconClinical Articles

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Prof Paul Griffin
Videos iconVideos

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access (8 mins).

Dr Gary Grohmann
Podcasts iconPodcasts

Vaccine-related injury, long COVID, more on boosters.

A/Prof John Litt AM
Videos iconVideos

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

Prof Adrian Esterman
Podcasts iconPodcasts

The current COVID situation- protect your vulnerable patients.

Dr Stuart Cooper
Clinical Articles iconClinical Articles

Don’t forget routine immunisations and use any patient contact as an opportunity for vaccination—says Professor Nick Wood of the National Centre for Immunisation Research & Surveillance at the University of Sydney.

Healthed
Clinical Articles iconClinical Articles

“Why didn’t anyone tell me about this virus?” is a frequent response I hear from parents upon learning their newborn is infected with cytomegalovirus, or CMV. Although more than half of the U.S. population will be infected with CMV by the age of 40 and the disease is common worldwide, few people have ever heard of it.

Expert/s: Healthed
Prof Adrian Esterman
Podcasts iconPodcasts

WHO vs ATAGI booster advice, which do we use? Antivirals - positive evidence for Molnupiravir emerges.

Dr Daryl Cheng
Videos iconVideos

In this Product Explainer, Paediatrician Dr Daryl Cheng explains the role of the MenACWY-TT conjugate vaccine for invasive meningococcal disease, the importance of adolescent vaccination and opportunistic immunisation, and the healthcare professional’s role in improving uptake rates in this age group (7 mins).

PP-NIM-AUS-0340. May 2023

Expert/s: Dr Daryl Cheng
Prof Paul Van Buynder
Videos iconVideos

In this Product Explainer, Public Health Physician Prof Paul Van Buynder explains the role of the Bivalent Original/Omicron BA.4-5 pre-filled syringe COVID-19 vaccine and provides an update on the situation in aged care, and how boosters can assist in protecting the community against symptomatic infection and severe disease (5 mins).

Emma Tinning
Clinical Articles iconClinical Articles

Only a fraction of aged care residents are getting COVID boosters, despite high influenza vaccination rates - why the mismatch?

Expert/s: Emma Tinning